Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02084966 · ClinicalTrials.gov registry record · NA

Non-Invasive Evaluation of Transplant Kidney Using OCT

A NA study, sponsored by Georgetown University.

Completed
Registry status
NA
Development phase
169
Enrollment target

NCT02084966 is a NA study that has completed, run by Georgetown University. The registered enrollment target is 169 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02084966, a NA study, has completed, sponsored by Georgetown University.

COMPLETED
Registry status
NA
Development phase
169 participants
Enrollment target

Study Summary

Optical coherence tomography (OCT) is a rapidly emerging imaging modality that can function as a type of "optical biopsy", providing non-invasive cross-sectional images of tissue architectural morphology in situ and in real-time. This proposal will demonstrate that OCT has the ability to provide novel and valuable histopathological information regarding donor kidneys that can be used to predict post-transplant renal function. These investigations will result in a major breakthrough in increasing the number of healthy kidneys available for transplantation by making the most efficient use of available donor kidneys, eliminating the possible use of bad donor kidneys, providing an accurate measure of expected post-transplant renal function, and allowing better distinction between post-transplant immunological rejection and ischemic-induced acute renal failure.

Interventions

  • PROCEDURE Procedure/Surgery: Transplantation: OCT of Kidney Transplant

Trial Details

FieldValue
Enrollment Target 169 participants
Start Date 2014-04
Est. Completion 2018-12
Phase NA

Sponsor

Georgetown University

227 total trials

What the Registry Record Tells You About NCT02084966

The ClinicalTrials.gov registry entry for NCT02084966 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 169 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Procedure/Surgery: Transplantation: OCT of Kidney Transplant is the first listed.

NCT02084966 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02084966 about?

NCT02084966 is a clinical study titled "Non-Invasive Evaluation of Transplant Kidney Using OCT". Optical coherence tomography (OCT) is a rapidly emerging imaging modality that can function as a type of "optical biopsy", providing non-invasive cross-sectional images of tissue architectural morphology in situ and in real-time. This proposal will demonstrate that OCT has the ability to provide nov...

What is the current status of trial NCT02084966?

This trial is currently completed. It is a NA study. The enrollment target is 169 participants. The study started on 2014-04. Estimated completion is 2018-12.

What interventions are being tested in trial NCT02084966?

The interventions under investigation include: Procedure/Surgery: Transplantation: OCT of Kidney Transplant (PROCEDURE).

Who is sponsoring clinical trial NCT02084966?

This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.